|
G
|
Ggt1
|
gamma-glutamyltransferase 1
|
decreases activity
|
EXP
|
Boric Acids analog results in decreased activity of GGT1 protein
|
CTD |
PMID:6149445 |
|
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
G
|
Muc1
|
mucin 1, cell surface associated
|
decreases expression
|
ISO
|
Boric Acids results in decreased expression of MUC1 mRNA
|
CTD |
PMID:21060261 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
G
|
Muc16
|
mucin 16, cell surface associated
|
decreases expression
|
ISO
|
Boric Acids results in decreased expression of MUC16 mRNA
|
CTD |
PMID:21060261 |
|
NCBI chr 8:24,440,840...24,644,494
|
|
|
G
|
Ace
|
angiotensin I converting enzyme
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [epigallocatechin gallate results in decreased activity of ACE protein]
|
CTD |
PMID:28544013 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
multiple interactions
|
EXP
|
boric acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of ACSL4 mRNA]; boric acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of ACSL4 protein]
|
CTD |
PMID:38108610 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
decreases expression
|
ISO
|
boric acid results in decreased expression of ACTA2 protein
|
CTD |
PMID:25637568 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]
|
CTD |
PMID:28285642 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of AGT mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases expression
|
ISO
|
boric acid results in increased expression of AKT1 mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
increases expression
|
EXP
|
boric acid results in increased expression of ALPL protein
|
CTD |
PMID:37045926 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
G
|
Arg1
|
arginase 1
|
decreases activity
|
ISO
|
boric acid results in decreased activity of ARG1 protein
|
CTD |
PMID:21232540 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
ISO
|
boric acid results in increased expression of ATF4 mRNA; boric acid results in increased expression of ATF4 protein
|
CTD |
PMID:25425213 PMID:27587023 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
G
|
Atf6
|
activating transcription factor 6
|
multiple interactions
|
ISO
|
boric acid results in increased cleavage of and affects the localization of ATF6 protein
|
CTD |
PMID:27587023 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
boric acid results in decreased expression of BAX mRNA [boric acid results in increased abundance of Boron] which affects the expression of BAX mRNA; [boric acid results in increased abundance of Boron] which affects the expression of BAX protein boric acid results in increased expression of BAX mRNA
|
CTD |
PMID:31368021 PMID:33137424 PMID:34175401 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
boric acid results in increased expression of BCL2 mRNA [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 mRNA; [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 protein boric acid results in decreased expression of BCL2 mRNA
|
CTD |
PMID:31368021 PMID:33137424 PMID:34175401 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression
|
ISO
|
boric acid results in decreased expression of BCL2L1 mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
increases expression
|
ISO
|
boric acid results in increased expression of BID mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Calr
|
calreticulin
|
increases expression
|
ISO
|
boric acid results in increased expression of CALR mRNA
|
CTD |
PMID:27587023 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
G
|
Casp3
|
caspase 3
|
decreases expression multiple interactions increases expression
|
ISO
|
boric acid results in decreased expression of CASP3 mRNA boric acid inhibits the reaction [Formaldehyde results in increased expression of CASP3 mRNA] boric acid results in increased expression of CASP3 mRNA
|
CTD |
PMID:31368021 PMID:31823256 PMID:34175401 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
increases expression
|
ISO
|
boric acid results in increased expression of CASP9 mRNA
|
CTD |
PMID:34175401 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
multiple interactions decreases activity decreases expression
|
EXP ISO
|
[boric acid co-treated with Arsenic Trioxide] affects the activity of CAT protein; [boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; boric acid inhibits the reaction [Acrylamide results in increased activity of CAT protein] boric acid affects the reaction [Formaldehyde results in decreased activity of CAT protein] boric acid results in decreased activity of CAT protein boric acid results in decreased expression of CAT protein
|
CTD |
PMID:26184899 PMID:29913234 PMID:30997025 PMID:31823256 PMID:37045926 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccnd1
|
cyclin D1
|
multiple interactions increases expression
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CCND1 protein] boric acid results in increased expression of CCND1 mRNA
|
CTD |
PMID:28285642 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]
|
CTD |
PMID:28285642 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
G
|
Col1a2
|
collagen type I alpha 2 chain
|
affects expression
|
ISO
|
boric acid affects the expression of COL1A2 mRNA
|
CTD |
PMID:24704097 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
G
|
Csf2
|
colony stimulating factor 2
|
increases expression
|
ISO
|
boric acid results in increased expression of CSF2 protein
|
CTD |
PMID:27206737 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
G
|
Csf3
|
colony stimulating factor 3
|
increases expression
|
ISO
|
boric acid results in increased expression of CSF3 protein
|
CTD |
PMID:27206737 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
G
|
Cst3
|
cystatin C
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [Acetaminophen results in increased expression of CST3 protein]
|
CTD |
PMID:35020164 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]
|
CTD |
PMID:28285642 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
decreases expression
|
ISO
|
boric acid results in decreased expression of DDIT3 mRNA; boric acid results in decreased expression of DDIT3 protein
|
CTD |
PMID:27587023 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Des
|
desmin
|
affects expression
|
ISO
|
boric acid affects the expression of DES mRNA
|
CTD |
PMID:25637568 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
G
|
Dvl2
|
dishevelled segment polarity protein 2
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of DVL2 mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr10:55,222,245...55,231,506
Ensembl chr10:55,222,056...55,231,506
|
|
G
|
Edem1
|
ER degradation enhancing alpha-mannosidase like protein 1
|
increases expression
|
ISO
|
boric acid results in increased expression of EDEM1 mRNA
|
CTD |
PMID:27587023 |
|
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060
|
|
G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
ISO
|
EIF2AK3 protein affects the reaction [boric acid affects the localization of NFE2L2 protein]; EIF2AK3 protein affects the reaction [boric acid results in increased expression of GCLC mRNA]; EIF2AK3 protein affects the reaction [boric acid results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:30196486 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
increases phosphorylation multiple interactions
|
ISO
|
boric acid results in increased phosphorylation of EIF2S1 protein EIF2AK3 protein affects the reaction [boric acid results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:25425213 PMID:27587023 PMID:30196486 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]
|
CTD |
PMID:28285642 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FASN mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fgf2
|
fibroblast growth factor 2
|
multiple interactions
|
ISO
|
boric acid promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FGF2 protein]
|
CTD |
PMID:28285642 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
G
|
Fgf7
|
fibroblast growth factor 7
|
increases expression
|
ISO
|
boric acid results in increased expression of FGF7 protein
|
CTD |
PMID:27206737 |
|
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328
|
|
G
|
Fn1
|
fibronectin 1
|
increases expression affects expression
|
ISO
|
boric acid results in increased expression of FN1 mRNA boric acid affects the expression of FN1 mRNA
|
CTD |
PMID:27206737 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
decreases expression
|
ISO
|
boric acid results in decreased expression of GAPDH protein
|
CTD |
PMID:28285642 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
G
|
Gas6
|
growth arrest specific 6
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of GAS6 protein]
|
CTD |
PMID:28285642 |
|
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
|
|
G
|
Gck
|
glucokinase
|
increases expression
|
ISO
|
boric acid results in increased expression of GCK mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression
|
ISO
|
EIF2AK3 protein affects the reaction [boric acid results in increased expression of GCLC mRNA]
|
CTD |
PMID:30196486 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
increases expression
|
EXP
|
boric acid results in increased expression of GOT1 protein
|
CTD |
PMID:37045926 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases expression
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in increased expression of GPT protein] boric acid results in increased expression of GPT protein
|
CTD |
PMID:30997025 PMID:37045926 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions
|
EXP
|
boric acid inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of GPX4 mRNA]; boric acid inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of GPX4 protein]
|
CTD |
PMID:38108610 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [Acetaminophen results in increased expression of HAVCR1 protein]
|
CTD |
PMID:35020164 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
increases expression
|
ISO
|
boric acid results in increased expression of HERPUD1 mRNA
|
CTD |
PMID:27587023 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression
|
ISO
|
boric acid results in increased expression of HMOX1 mRNA
|
CTD |
PMID:30196486 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hoxa6
|
homeobox A6
|
affects expression
|
EXP
|
boric acid affects the expression of HOXA6 mRNA
|
CTD |
PMID:12749385 |
|
NCBI chr 4:82,637,024...82,639,463
|
|
G
|
Hoxc6
|
homeo box C6
|
affects expression
|
EXP
|
boric acid affects the expression of HOXC6 mRNA
|
CTD |
PMID:12749385 |
|
NCBI chr 7:136,013,679...136,051,601
Ensembl chr 7:136,024,961...136,027,365
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
boric acid results in increased expression of HSPA5 mRNA; boric acid results in increased expression of HSPA5 protein
|
CTD |
PMID:25425213 PMID:27587023 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased secretion of IFNG protein]; [boric acid results in increased abundance of Boron] which affects the secretion of IFNG protein; [Food Preservatives results in increased abundance of boric acid] which results in increased expression of IFNG mRNA; boric acid inhibits the reaction [Acrylamide results in increased expression of IFNG mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG protein]
|
CTD |
PMID:29913234 PMID:30368975 PMID:32179172 PMID:33137424 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in decreased expression of IL10 mRNA]; [Food Preservatives results in increased abundance of boric acid] which results in increased expression of IL10 mRNA
|
CTD |
PMID:30997025 PMID:32179172 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il18
|
interleukin 18
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [Acetaminophen results in increased expression of IL18 protein]
|
CTD |
PMID:35020164 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in increased expression of IL1B mRNA]; [Food Preservatives results in increased abundance of boric acid] which results in increased expression of IL1B mRNA; boric acid inhibits the reaction [Acrylamide results in increased expression of IL1B mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]
|
CTD |
PMID:29913234 PMID:30368975 PMID:30997025 PMID:32179172 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il2
|
interleukin 2
|
multiple interactions
|
EXP
|
[boric acid results in increased abundance of Boron] promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased secretion of IL2 protein]; [boric acid results in increased abundance of Boron] which results in decreased secretion of IL2 protein
|
CTD |
PMID:33137424 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
G
|
Il4
|
interleukin 4
|
increases expression multiple interactions
|
ISO EXP
|
boric acid results in increased expression of IL4 mRNA [boric acid results in increased abundance of Boron] which affects the secretion of IL4 protein
|
CTD |
PMID:31368021 PMID:33137424 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO EXP
|
boric acid promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of IL6 mRNA] [boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in increased expression of IL6 mRNA]; [Food Preservatives results in increased abundance of boric acid] which results in increased expression of IL6 mRNA
|
CTD |
PMID:28285642 PMID:30997025 PMID:32179172 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Ins1
|
insulin 1
|
increases expression
|
ISO
|
boric acid results in increased expression of INS1 mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
G
|
Ins2
|
insulin 2
|
multiple interactions increases expression
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CCND1 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of DVL2 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of AGT mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FASN mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of GAS6 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of KLF5 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LEP mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LIPE mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SLC2A4 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SLC2A4 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SREBF1 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of TNFRSF1A protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; boric acid promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FGF2 protein]; boric acid promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of IL6 mRNA]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]] boric acid results in increased expression of INS2 mRNA
|
CTD |
PMID:28285642 PMID:31368021 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
G
|
Klf5
|
KLF transcription factor 5
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of KLF5 mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262
|
|
G
|
Lama5
|
laminin subunit alpha 5
|
increases expression
|
ISO
|
boric acid results in increased expression of LAMA5 mRNA
|
CTD |
PMID:27206737 |
|
NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173
|
|
G
|
Lep
|
leptin
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LEP mRNA]; boric acid results in decreased expression of and results in decreased secretion of LEP protein
|
CTD |
PMID:28285642 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Lipe
|
lipase E, hormone sensitive type
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LIPE mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:28285642 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:28285642 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mir130a
|
microRNA 130a
|
decreases expression
|
ISO
|
boric acid results in decreased expression of MIR130A mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr 3:90,229,228...90,229,315
|
|
G
|
Mir200a
|
microRNA 200a
|
decreases expression
|
ISO
|
boric acid results in decreased expression of MIR200A mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr 5:171,930,717...171,930,805
|
|
G
|
Mir21
|
microRNA 21
|
decreases expression
|
ISO
|
boric acid results in decreased expression of MIR21 mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr10:71,902,600...71,902,691
|
|
G
|
Mir224
|
microRNA 224
|
decreases expression
|
ISO
|
boric acid results in decreased expression of MIR224 mRNA
|
CTD |
PMID:34175401 |
|
NCBI chr X:155,107,130...155,107,211
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
boric acid results in decreased expression of MMP2 protein
|
CTD |
PMID:28285642 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
G
|
Myh1
|
myosin heavy chain 1
|
affects expression
|
ISO
|
boric acid affects the expression of MYH1 mRNA
|
CTD |
PMID:25637568 |
|
NCBI chr10:52,384,810...52,408,698
Ensembl chr10:52,384,908...52,409,047
|
|
G
|
Myod1
|
myogenic differentiation 1
|
affects expression decreases expression
|
ISO
|
boric acid affects the expression of MYOD1 mRNA boric acid results in decreased expression of MYOD1 protein
|
CTD |
PMID:25637568 |
|
NCBI chr 1:106,021,161...106,023,871
Ensembl chr 1:106,021,161...106,023,871
|
|
G
|
Myog
|
myogenin
|
affects expression
|
ISO
|
boric acid affects the expression of MYOG mRNA
|
CTD |
PMID:25637568 |
|
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects localization multiple interactions
|
ISO
|
boric acid affects the localization of NFE2L2 protein EIF2AK3 protein affects the reaction [boric acid affects the localization of NFE2L2 protein]
|
CTD |
PMID:30196486 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions increases expression affects expression
|
ISO EXP
|
boric acid affects the reaction [Formaldehyde results in increased expression of NFKB1 mRNA] boric acid results in increased expression of NFKB1 mRNA boric acid affects the expression of NFKB1 mRNA
|
CTD |
PMID:31823256 PMID:37045926 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
|
CTD |
PMID:27206737 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression
|
ISO
|
boric acid results in increased expression of NQO1 mRNA
|
CTD |
PMID:30196486 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
increases expression multiple interactions
|
EXP
|
boric acid results in increased expression of PCNA protein [boric acid results in increased abundance of Boron] promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of PCNA protein]; [boric acid results in increased abundance of Boron] which affects the expression of PCNA protein; [boric acid results in increased abundance of Boron] which results in decreased expression of PCNA mRNA
|
CTD |
PMID:17943231 PMID:33137424 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
increases expression
|
ISO
|
boric acid results in increased expression of PDX1 mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]
|
CTD |
PMID:28285642 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
boric acid results in increased expression of PPP1R15A mRNA; boric acid results in increased expression of PPP1R15A protein
|
CTD |
PMID:27587023 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:27206737 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP
|
boric acid inhibits the reaction [Acrylamide results in increased expression of RELA mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of RELA mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]
|
CTD |
PMID:29913234 PMID:30368975 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Runx2
|
RUNX family transcription factor 2
|
affects expression
|
ISO
|
boric acid affects the expression of RUNX2 mRNA
|
CTD |
PMID:24704097 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
G
|
Slc2a2
|
solute carrier family 2 member 2
|
increases expression
|
ISO
|
boric acid results in increased expression of SLC2A2 mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
G
|
Slc2a4
|
solute carrier family 2 member 4
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SLC2A4 mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SLC2A4 protein]
|
CTD |
PMID:28285642 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
G
|
Slc4a2
|
solute carrier family 4 member 2
|
increases expression
|
ISO
|
boric acid results in increased expression of SLC4A2 mRNA
|
CTD |
PMID:22576912 |
|
NCBI chr 4:11,628,860...11,646,961
Ensembl chr 4:11,628,862...11,645,402
|
|
G
|
Slc4a3
|
solute carrier family 4 member 3
|
increases expression
|
ISO
|
boric acid results in increased expression of SLC4A3 mRNA
|
CTD |
PMID:22576912 |
|
NCBI chr 9:84,484,749...84,497,746
Ensembl chr 9:84,485,085...84,497,738
|
|
G
|
Sod1
|
superoxide dismutase 1
|
decreases expression
|
EXP
|
boric acid results in decreased expression of SOD1 protein
|
CTD |
PMID:37045926 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sparc
|
secreted protein acidic and cysteine rich
|
affects expression
|
ISO
|
boric acid affects the expression of SPARC mRNA
|
CTD |
PMID:24704097 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:28285642 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
G
|
Syvn1
|
synoviolin 1
|
decreases expression
|
ISO
|
boric acid results in decreased expression of SYVN1 mRNA
|
CTD |
PMID:27587023 |
|
NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:212,768,907...212,776,457
|
|
G
|
Tfrc
|
transferrin receptor
|
multiple interactions
|
EXP
|
boric acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of TFRC mRNA]; boric acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of TFRC protein]
|
CTD |
PMID:38108610 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression
|
ISO
|
boric acid results in increased expression of TGFB1 protein boric acid results in increased expression of TGFB1 mRNA
|
CTD |
PMID:27206737 PMID:31368021 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tlr2
|
toll-like receptor 2
|
increases expression
|
EXP
|
boric acid results in increased expression of TLR2 mRNA
|
CTD |
PMID:37045926 |
|
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
G
|
Tlr4
|
toll-like receptor 4
|
increases expression
|
EXP
|
boric acid results in increased expression of TLR4 mRNA
|
CTD |
PMID:37045926 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression decreases expression increases secretion
|
ISO EXP
|
boric acid inhibits the reaction [Formaldehyde results in increased expression of TNF mRNA]; boric acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; boric acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] boric acid results in increased expression of TNF mRNA boric acid results in decreased expression of TNF mRNA [boric acid results in increased abundance of Boron] inhibits the reaction [bisphenol A results in increased expression of TNF mRNA]; [Food Preservatives results in increased abundance of boric acid] which results in increased expression of TNF mRNA; boric acid inhibits the reaction [Acrylamide results in increased expression of TNF mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of TNF mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein] boric acid results in increased secretion of TNF protein
|
CTD |
PMID:9618283 PMID:18755394 PMID:29913234 PMID:30368975 PMID:30997025 PMID:31823256 PMID:32179172 PMID:37045926 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
multiple interactions
|
ISO
|
boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of TNFRSF1A protein]
|
CTD |
PMID:28285642 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
G
|
Tp53
|
tumor protein p53
|
decreases expression
|
ISO
|
boric acid results in decreased expression of TRP53 mRNA
|
CTD |
PMID:31368021 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Xbp1
|
X-box binding protein 1
|
increases expression
|
ISO
|
boric acid results in increased expression of XBP1 mRNA
|
CTD |
PMID:27587023 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|